Cargando…
Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkin's Lymphoma Patients with Chemotherapy Regimens
In this study we surveyed the average survival time of the treated Hodgkin's lymphoma patients and also the side effects and malignancies occurring secondary to the treatment. This is a retrospective study of patients referring to Ahwaz's Shafa hospital in a period of 10 years diagnosed wi...
Autores principales: | Ahmadzadeh, Ahmad, Yekaninejad, Mir Saeed, Jalili, Mohamad H, Bahadoram, Mohammad, Efazat, Mehdi, Seghatoleslami, Mohammad, Yazdi, Fatemeh, Mahdipour, Mozhdeh, Valizadeh, Armita, Saki, Najmaldin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003439/ https://www.ncbi.nlm.nih.gov/pubmed/24800035 |
Ejemplares similares
-
Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group
por: Safaee, Reza, et al.
Publicado: (2012) -
Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
por: Javanmardi, Fatemeh, et al.
Publicado: (2018) -
Infection Pattern of Neutropenic Patients in Post-chemotherapy Phase of Acute Leukemia Treatment
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2013) -
Coexistence of p190 BCR/ABL Transcript and CALR 52-bp Deletion in Chronic Myeloid Leukemia Blast Crisis: A Case Report
por: Seghatoleslami, Mohammad, et al.
Publicado: (2016) -
Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy
por: Shahjahani, Mohammad, et al.
Publicado: (2015)